Table: RaQualia Pharma -2022 parent results

RaQualia Pharma

14/02/2023 06:15

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             2.68            2.36                                 
                 (+13.5 pct)    (+134.0 pct)                             
  Operating        683 mln         505 mln                               
                 (+35.1 pct)                                             
  Recurring        701 mln         656 mln                               
                 (+6.9 pct)                                              
  Net              583 mln         614 mln                               
                 (-5.1 pct)                                              
  EPS             27.83 yen       29.34 yen                              
  EPS Diluted     27.81 yen       29.31 yen                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T